Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.

ABSTRACT:

Background

This study examined sociodemographic factors, cisplatin-related adverse health outcomes (AHO), and cumulative burden of morbidity (CBM_Pt) scores associated with medication use for anxiety and/or depression in testicular cancer survivors (TCS).

Methods

A total of 1,802 TCS who completed cisplatin-based chemotherapy ≥12 months previously completed questionnaires regarding sociodemographic features and cisplatin-related AHOs [hearing impairment, tinnitus, peripheral sensory neuropathy (PSN), and kidney disease]. A CBM_Pt score encompassed the number and severity of cisplatin-related AHOs. Multivariable logistic regression models assessed the relationship of individual AHOs and CBM_Pt with medication use for anxiety and/or depression.

SUBMITTER: ArdeshirRouhaniFard S 

PROVIDER: S-EPMC8172470 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature